Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07208682 · ClinicalTrials.gov registry record · NA
Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings
A NA study of Bladder Perforation and Retropubic Midurethral Sling, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT07208682: Recruiting NA study of Bladder Perforation and Retropubic Midurethral Sling, sponsored by University of Massachusetts, Worcester.
NCT07208682 is a NA study of Bladder Perforation and Retropubic Midurethral Sling that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07208682, a NA study of Bladder Perforation and Retropubic Midurethral Sling, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Retropubic midurethral slings are a common and effective treatment for stress urine incontinence. The trocar that is attached to the mesh material can hit the bladder which is called a perforation. While there are no known long-term adverse outcomes from trocar-induced bladder perforations, it can prolong operative time and bleeding. At academic institutions, it has been reported that trocar-induced perforations occurs in the range of 14-34% of the time. This study is a randomized controlled trial to see if an intervention can decrease trocar-induced bladder perforation rates. The primary outcome of this study is to measure trocar-induced bladder perforations in subjects undergoing a retropubic midurethral sling. Subjects would be randomized to either receive the hydrodissection in a standardized manner or to not receive it. Secondary outcomes include bothersome urinary symptoms, pain, estimated blood loss during surgery, and voiding trial results
Primary Outcome
the number of trocar-induced bladder perforations during one case would be measured
Conditions Studied
Interventions
- PROCEDURE retropubic hydrodissection
Study Locations (1)
Massachusetts
- University of Massachusetts Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-04-03 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07208682 shows while recruiting
NCT07208682 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 3 conditions, with Bladder Perforation appearing as the primary indexed condition, and to 1 intervention - of which retropubic hydrodissection is the first listed.
NCT07208682 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07208682 about?
NCT07208682 is a clinical study titled "Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings". Retropubic midurethral slings are a common and effective treatment for stress urine incontinence. The trocar that is attached to the mesh material can hit the bladder which is called a perforation. While there are no known long-term adverse outcomes from trocar-induced bladder perforations, it can p...
What is the current status of trial NCT07208682?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-04-03. Estimated completion is 2027-06.
What conditions does trial NCT07208682 study?
This clinical trial studies the following conditions: Bladder Perforation, Retropubic Midurethral Sling, Retropubic Hydrodissection.
What interventions are being tested in trial NCT07208682?
The interventions under investigation include: retropubic hydrodissection (PROCEDURE).
Who is sponsoring clinical trial NCT07208682?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07208682 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07208682's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI